BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8614375)

  • 1. Pain palliation with strontium-89 in children with metastatic disease.
    Charron M; Brown M; Rowland P; Mirro J
    Med Pediatr Oncol; 1996 Jun; 26(6):393-6. PubMed ID: 8614375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone pain palliation with 85Sr therapy.
    Giammarile F; Mognetti T; Blondet C; Desuzinges C; Chauvot P
    J Nucl Med; 1999 Apr; 40(4):585-90. PubMed ID: 10210217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Bone pain palliation with strontium-89 in children".
    Giammarile F; Chauvot P
    Med Pediatr Oncol; 1998 Mar; 30(3):199-200. PubMed ID: 9434836
    [No Abstract]   [Full Text] [Related]  

  • 4. Strontium-89 for the palliation of bone pain due to metastatic disease.
    Taylor AJ
    J Nucl Med; 1994 Dec; 35(12):2054. PubMed ID: 7527458
    [No Abstract]   [Full Text] [Related]  

  • 5. Bone pain palliation with strontium-89 in cancer patients with bone metastases.
    Giammarile F; Mognetti T; Resche I
    Q J Nucl Med; 2001 Mar; 45(1):78-83. PubMed ID: 11456379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palliation of bone pain in patients with metastatic cancer using strontium-89 (Metastron).
    Kan MK
    Cancer Nurs; 1995 Aug; 18(4):286-91. PubMed ID: 7545083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radionuclide-targeted therapy for the management of metastatic bone pain.
    Ackery D; Yardley J
    Semin Oncol; 1993 Jun; 20(3 Suppl 2):27-31. PubMed ID: 7684862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitation of biochemical markers of bone resorption following strontium-89-chloride therapy for metastatic prostatic carcinoma.
    Papatheofanis FJ
    J Nucl Med; 1997 Aug; 38(8):1175-9. PubMed ID: 9255144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation in oncologic opinion regarding management of metastatic bone pain with systemic radionuclide therapy.
    Papatheofanis FJ
    J Nucl Med; 1999 Sep; 40(9):1420-3. PubMed ID: 10492359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic effects of strontium-89 against osseous metastases of lung cancer: analysis of 126 cases].
    Zheng H; Luo RC; Fan YX
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Oct; 24(10):1194-6. PubMed ID: 15485798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased serum E-selectin concentration after 89Sr-chloride therapy for metastatic prostate cancer bone pain.
    Papatheofanis FJ
    J Nucl Med; 2000 Jun; 41(6):1021-4. PubMed ID: 10855628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypocalcemia associated with strontium-89 administration in a patient with diffuse bone metastases from neuroendocrine carcinoma.
    Mori M; Fadul NA; Bruera E; Dalal S
    J Pain Symptom Manage; 2009 May; 37(5):923-9. PubMed ID: 19041217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
    Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
    Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic efficacy of strontium-89-chloride for bone metastatic tumors without bone pain].
    Ouyang W; Liu JH; Liu WY
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):390-1. PubMed ID: 17426002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 89Strontium in the management of painful sceletal metastases.
    Kälkner KM; Westlin JE; Strang P
    Anticancer Res; 2000; 20(2B):1109-14. PubMed ID: 10810404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strontium-89 for palliation of bone pain.
    Gompakis N; Triantafyllou P; Sidi B; Koliouskas ED; Salem N; Pistevou K
    Med Pediatr Oncol; 2003 Feb; 40(2):136. PubMed ID: 12461806
    [No Abstract]   [Full Text] [Related]  

  • 17. Palliative radiotherapy in children with neuroblastoma.
    Paulino AC
    Pediatr Hematol Oncol; 2003 Mar; 20(2):111-7. PubMed ID: 12554522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment of painful osteoblastic metastases: what can we expect from nuclear oncology?
    Silberstein EB
    J Nucl Med; 1994 Dec; 35(12):1994-5. PubMed ID: 7527457
    [No Abstract]   [Full Text] [Related]  

  • 19. [Radioactive substances (32P and 89Sr) in the treatment of pain in bone metastases].
    Flamm J; Burkert S
    Z Urol Nephrol; 1981 Nov; 74(11):801-6. PubMed ID: 6172913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative efficacy of 32P and 89Sr in palliation in skeletal metastases.
    Nair N
    J Nucl Med; 1999 Feb; 40(2):256-61. PubMed ID: 10025832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.